Show simple item record

HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B

dc.contributor.authorHansen, B.
dc.contributor.authorTabak, F.
dc.contributor.authorFeld, J.
dc.contributor.authorJanssen, H.
dc.contributor.authorCakaloglu, Y.
dc.contributor.authorFarag, M.
dc.contributor.authorCampenhout, M. V.
dc.contributor.authorvan Boemmel, F.
dc.contributor.authorRijckborst, V.
dc.contributor.authorFerenci, P.
dc.date.accessioned2021-03-03T14:30:09Z
dc.date.available2021-03-03T14:30:09Z
dc.identifier.citationFarag M., Campenhout M. V. , van Boemmel F., Rijckborst V., Cakaloglu Y., Ferenci P., Tabak F., Feld J., Hansen B., Janssen H., "HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B", International Liver Congress (ILC), Paris, Fransa, 11 - 15 Nisan 2018, cilt.68
dc.identifier.othervv_1032021
dc.identifier.otherav_39eec05c-760b-406f-bee6-2ec38cb2b1d8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/42933
dc.identifier.urihttps://doi.org/10.1016/s0168-8278(18)31269-8
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleHBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B
dc.typeBildiri
dc.contributor.departmentUniversity Of Toronto , ,
dc.identifier.volume68
dc.contributor.firstauthorID153176


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record